Truveris

Private

Wilmington, DelawareEnterprise Softwarehttps://truveris.com/

Last Round

Series E

May 14, 2024

Total Funding Raised

$66.55M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Truveris is a healthcare technology company that provides a pharmacy benefits procurement and insights platform to reduce prescription drug costs.

Sector

Enterprise Software

Verticals

Healthcare Analytics, Pharma Supply Chain, Vertical SaaS, Compliance

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Marketplace Commission, Government Contracts

AI Layer

Application

Keywords

pharmacy benefit managementPBM managementPBM oversightprescription cost containmentPBM procurementPBM marketplacePBM auditPBM analyticsPBM carve-outclaims re-adjudicationPBM advisoryfiduciary compliancehealthcare cost containmentself-funded employersemployee benefits platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Truveris Comps

Public and private peers based on sector, stage, and business model.

Truveris comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Truveris Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series E	May 14, 2024
Series D	Sep 6, 2017
Series C	Jun 27, 2014
Series B	Feb 23, 2012
Series A	Feb 1, 2011

View all Funding Rounds

Key People

Founding team and executive leadership

Garrett Fienberg

Chief Operating Officer (former Chief Of Growth Operations)

Executive Team

Truveris Investors

Notable investors and investment history

Truveris investors
Investor	Rounds
GSA Venture Partners	Series A
New Leaf Venture Partners	Series C, Series D, Series E, Series B
McKesson Ventures	Series D
Canaan Partners	Series D, Series E, Series C
First Round Capital	Series C, Series B, Series A
NAV.VC	Series C, Series B, Series D, Series A
Tribeca Venture Partners	Series C, Series B, Series D

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 17, 2026
Monthly visitors increased 80% MoM.
Feb 26, 2025
Monthly visitors grew 43% MoM, reaching 6.3K.

View all signals

Truveris Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Truveris Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Truveris's valuation, stock price, and market status.

Firmographic Details

HeadquartersWilmington, Delaware

Employee Range92

Year Founded2009

Last FundingMay 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.